NCT06860386 2026-03-06Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCCH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Suspended75 enrolled
NCT03316573 2026-02-10Pembrolizumab in Neoplasms or LymphomasDana-Farber Cancer InstitutePhase 2 Suspended18 enrolled 16 charts